Cited 20 times in
Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.